Postma, Maarten J <br/><br/>
Economic evaluation of dabigatran etexilate for the primary prevention of venous tromboembolic events following major orthopedic surgery in the Netherlands.  [electronic resource] 

 -  Journal of medical economics  2012 
 - 878-86 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1941-837X 
<br/><br/><label>Standard No.: </label>10.3111/13696998.2012.691144  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Benzimidazoles--administration & dosage<br/>Cohort Studies<br/>Cost-Benefit Analysis<br/>Dabigatran<br/>Female<br/>Fibrinolytic Agents--administration & dosage<br/>Humans<br/>Infusions, Subcutaneous<br/>Male<br/>Middle Aged<br/>Netherlands<br/>Orthopedics<br/>Postoperative Complications--prevention & control<br/>Primary Prevention<br/>Pyridines--administration & dosage<br/>Retrospective Studies<br/>Venous Thromboembolism--prevention & control